港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

同源康醫藥-B

27.050

-0.250-0.92%

成交量：352.55萬

成交額：9,554.13萬

市值：100.36億

市盈率：-22.12

高：27.800

開：27.300

低：26.600

收：27.300

資料載入中...

總覽公司新聞公告

同源康醫藥-B(02410)完成H股全流通

同源康醫藥(02410.HK)完成H股全流通

阿斯达克财经

同源康醫藥-B盤中異動大幅跳水5.10%報29.800港元

同源康醫藥-B盤中異動早盤股價大漲6.13%

同源康醫藥-B盤中異動下午盤股價大漲5.31%

同源康醫藥－Ｂ(02410)股價上升5.096%，現價港幣$24.75

阿斯达克财经

同源康醫藥-B盤中異動股價大漲6.58%報23.500港元

同源康醫藥獲批轉換1.74億股非上市股份為H股

同源康醫藥(02410.HK)H股全流通獲授上市批准

阿斯达克财经

同源康醫藥-B：H股全流通獲上市批准

同源康醫藥-B(02410)：H股全流通獲上市批准

同源康醫藥-B盤中異動股價大漲6.67%

同源康醫藥-B盤中異動早盤大幅下挫5.06%

同源康醫藥-B盤中異動快速跳水7.20%報23.200港元

同源康醫藥受邀參加第43屆摩根大通醫療健康大會（JPM大會）

恒指重回20000點上方，同源康醫藥-B漲超22%

港股異動 | 同源康醫藥-B(02410)盤中漲超34% 核心產品正進行臨牀試驗機構指其具備較強競爭

同源康醫藥-B盤中異動大幅拉昇6.60%

同源康醫藥－Ｂ(02410)股價上升9.756%，現價港幣$18.0

阿斯达克财经

同源康醫藥-B盤中異動下午盤大幅拉昇6.71%

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/02410/news?page=4"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02410","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","market":"HK","secType":"STK","nameCN":"同源康醫藥-B","latestPrice":27.05,"timestamp":1745914087032,"preClose":27.3,"halted":0,"volume":3525500,"delay":0,"floatShares":366000000,"shares":371000000,"eps":-1.2226211830602365,"marketStatus":"已收盤","change":-0.25,"latestTime":"04-29 16:08:07","open":27.3,"high":27.8,"low":26.6,"amount":95541305,"amplitude":0.043956,"askPrice":27.05,"askSize":3500,"bidPrice":26.85,"bidSize":1500,"shortable":3,"etf":0,"ttmEps":-1.2226211830602365,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745976600000},"marketStatusCode":5,"adr":0,"listingDate":1724083200000,"exchange":"SEHK","adjPreClose":27.3,"openAndCloseTimeList":[[1745890200000,1745899200000],[1745902800000,1745913600000]],"volumeRatio":1.612173,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02410\",,,,,undefined,":{"symbol":"02410","floatShares":366000000,"roa":"-28.86%","roe":"--","lyrEps":-1.222621,"volumeRatio":1.612173,"shares":371000000,"dividePrice":0,"high":27.8,"amplitude":0.043956,"preClose":27.3,"low":26.6,"week52Low":12.86,"pbRate":"20.06","psRate":"87923.06","week52High":56.55,"institutionHeld":0,"latestPrice":27.05,"committee":-0.4,"eps":-1.2226211830602365,"divideRate":0,"volume":3525500,"delay":0,"ttmEps":-1.2226211830602365,"open":27.3,"prevYearClose":47.15,"prevWeekClose":27.5,"prevMonthClose":34.2,"prevQuarterClose":34.2,"fiveDayClose":28,"twentyDayClose":35,"sixtyDayClose":22.65},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02410\",pageSize:20,pageCount:4,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512136528","title":"同源康醫藥-B(02410)完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2512136528","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512136528?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 16:31","pubTimestamp":1739867473,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布公告，1.74亿股非上市股份已于2025年2月18日完成转换为H股，该等经转换H股将于2025年2月19日上午9时正开始于联交所上市。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1251116.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","BK1515","159938","09939","02410","BK1161"],"gpt_icon":0},{"id":"2512213662","title":"同源康醫藥(02410.HK)完成H股全流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2512213662","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512213662?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 16:30","pubTimestamp":1739867400,"startTime":"0","endTime":"0","summary":"同源康医药－Ｂ(02410.HK) 完成H股全流通，约1.74亿股非上市股份已于2月18日(今日)完成转换为H股，该等经转换H股将于2月19日上午九时正开始于联交所上市。(ha/u)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20240819111846765_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20240819111846765_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1418148/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","BK1515","BK1161","BK1574","09939","02410"],"gpt_icon":0},{"id":"2512044779","title":"同源康醫藥-B盤中異動 大幅跳水5.10%報29.800港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512044779","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512044779?lang=zh_tw&edition=fundamental","pubTime":"2025-02-18 10:51","pubTimestamp":1739847103,"startTime":"0","endTime":"0","summary":"2025年02月18日早盘10时51分，同源康医药-B股票出现波动，股价急速下跌5.10%。截至发稿，该股报29.800港元/股，成交量10.8万股，换手率0.06%，振幅8.92%。资金方面，该股资金流入121.8万港元，流出207.035万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，奥星生命科技、来凯医药-B、诺诚健华涨幅较大，振幅较大的相关个股有来凯医药-B、奥星生命科技、圣诺医药-B，振幅分别为23.54%、21.54%、16.29%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218105144a249f11d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218105144a249f11d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","09939","BK1515","BK1574"],"gpt_icon":0},{"id":"2512236998","title":"同源康醫藥-B盤中異動 早盤股價大漲6.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512236998","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512236998?lang=zh_tw&edition=fundamental","pubTime":"2025-02-17 10:43","pubTimestamp":1739760227,"startTime":"0","endTime":"0","summary":"2025年02月17日早盘10时43分，同源康医药-B股票出现波动，股价大幅拉升6.13%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.36%。其相关个股中，云顶新耀-B、奥星生命科技、科济药业-B涨幅较大，振幅较大的相关个股有维亚生物、云顶新耀-B、贝康医疗-B，振幅分别为22.73%、16.09%、11.23%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217104347988814ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250217104347988814ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1574","BK1515","09939","02410","BK1161"],"gpt_icon":0},{"id":"2511633220","title":"同源康醫藥-B盤中異動 下午盤股價大漲5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511633220","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511633220?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 13:20","pubTimestamp":1739510437,"startTime":"0","endTime":"0","summary":"2025年02月14日下午盘13时20分，同源康医药-B股票出现异动，股价快速拉升5.31%。同源康医药-B股票所在的生物技术行业中，整体涨幅为3.38%。其相关个股中，维亚生物、华领医药-B、泰格医药涨幅较大，振幅较大的相关个股有方达控股、维亚生物、瑞科生物-B，振幅分别为18.24%、15.31%、13.33%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141320379884f6ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502141320379884f6ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1161","02410","09939","BK1574"],"gpt_icon":0},{"id":"2511980635","title":"同源康醫藥－Ｂ(02410)股價上升5.096%，現價港幣$24.75","url":"https://stock-news.laohu8.com/highlight/detail?id=2511980635","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511980635?lang=zh_tw&edition=fundamental","pubTime":"2025-02-14 13:20","pubTimestamp":1739510400,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午01:20比前收市价上升5.096%，现股价为港币$24.75。至目前为止，今日最高价为$24.75，而最低价为$23.75。总成交量为3.5万股，总成交金额为港币$84.775万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2502145558/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02410","BK1161","BK1515","BK1574","09939","159938"],"gpt_icon":0},{"id":"2511567418","title":"同源康醫藥-B盤中異動 股價大漲6.58%報23.500港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511567418","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511567418?lang=zh_tw&edition=fundamental","pubTime":"2025-02-13 13:48","pubTimestamp":1739425687,"startTime":"0","endTime":"0","summary":"2025年02月13日下午盘13时48分，同源康医药-B股票出现波动，股价急速拉升6.58%。截至发稿，该股报23.500港元/股，成交量11万股，换手率0.06%，振幅4.99%。资金方面，该股资金流入13.745万港元，流出236.597万港元。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.28%。其相关个股中，再鼎医药、科笛-B、同源康医药-B涨幅较大，振幅较大的相关个股有北海康成-B、创胜集团-B、科笛-B，振幅分别为18.05%、14.71%、13.95%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502131348079883aac8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502131348079883aac8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","09939","02410","BK1161","BK1574"],"gpt_icon":0},{"id":"2510484692","title":"同源康醫藥獲批轉換1.74億股非上市股份為H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2510484692","media":"财中社","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510484692?lang=zh_tw&edition=fundamental","pubTime":"2025-02-11 09:30","pubTimestamp":1739237449,"startTime":"0","endTime":"0","summary":"财中社2月11日电 同源康医药（02410）发布公告，宣布公司已获得香港联合交易所的上市批准，允许将1.74亿股非上市股份转换为H股并上市交易。这一转换涉及25名股东，其持有的经转换H股数量占公司截至公告日期已发行股份总数的约46.82%。公告提到，转换后的H股将显著增加公司的流通股本，预计将有助于提高市场流动性。在股权结构方面，公告显示，转换完成后，公司的H股总数将由1.93亿股增加至3.66亿股，占总股本的98.76%。而非上市股份将减少至461万股，占总股本的1.24%。公司董事会表示，将根据上市规则及适用法律完成相关的转换及买卖手续，并会及时更新进展情况。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211093645a2413141&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250211093645a2413141&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1574","BK1515","09939","02410"],"gpt_icon":0},{"id":"2510810574","title":"同源康醫藥(02410.HK)H股全流通獲授上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2510810574","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510810574?lang=zh_tw&edition=fundamental","pubTime":"2025-02-11 08:12","pubTimestamp":1739232720,"startTime":"0","endTime":"0","summary":"同源康医药-B(02410.HK) 公布，已向联交所上市委员会申请，批准该公司根据转换其25名股东持有的1.73亿股非上市股份转换的1.73亿股H股上市，以及买卖经转换H股。联交所已于周一(10日)授出上市批准。(js/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20241219145546393_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20241219145546393_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1416183/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["159938","02410","BK1515","09939","BK1161","BK1574"],"gpt_icon":0},{"id":"2510817661","title":"同源康醫藥-B：H股全流通獲上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2510817661","media":"新浪港股","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510817661?lang=zh_tw&edition=fundamental","pubTime":"2025-02-11 08:11","pubTimestamp":1739232660,"startTime":"0","endTime":"0","summary":"热点栏目\n\n自选股\n数据中心\n行情中心\n资金流向\n模拟交易\n\n客户端\n\n\n　　同源康医药-B（02410）发布公告，公司已向联交所上市委员会申请批准公司根据转换公司25名股东持有的1.74亿股非上市股份转换的1.74亿股H股（经转换H股）上市及买卖经转换H股（上市批准）。公司欣然宣布，联交所已于2025年2月10日授出上市批准。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：卢昱君","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2025-02-11/doc-inekafyp6845492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1574","BK1161","159938","09939","BK1515","02410"],"gpt_icon":0},{"id":"2510865912","title":"同源康醫藥-B(02410)：H股全流通獲上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2510865912","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510865912?lang=zh_tw&edition=fundamental","pubTime":"2025-02-10 22:23","pubTimestamp":1739197417,"startTime":"0","endTime":"0","summary":"智通财经APP讯，同源康医药-B(02410)发布公告，公司已向联交所上市委员会申请批准公司根据转换公司25名股东持有的1.74亿股非上市股份转换的1.74亿股H股(经转换H股)上市及买卖经转换H股(上市批准)。公司欣然宣布，联交所已于2025年2月10日授出上市批准。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1248051.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09939","BK1161","BK1574","02410","159938","BK1515"],"gpt_icon":0},{"id":"2509694457","title":"同源康醫藥-B盤中異動 股價大漲6.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509694457","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2509694457?lang=zh_tw&edition=fundamental","pubTime":"2025-02-07 13:57","pubTimestamp":1738907877,"startTime":"0","endTime":"0","summary":"2025年02月07日下午盘13时57分，同源康医药-B股票出现异动，股价急速上涨6.67%。资金方面，该股资金流入9.8475万港元，流出2万港元。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。同源康医药-B股票所在的生物技术行业中，整体跌幅为0.37%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207135757961ac8fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207135757961ac8fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1515","BK1574","09939","BK1161"],"gpt_icon":0},{"id":"2508109233","title":"同源康醫藥-B盤中異動 早盤大幅下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508109233","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2508109233?lang=zh_tw&edition=fundamental","pubTime":"2025-02-04 10:22","pubTimestamp":1738635774,"startTime":"0","endTime":"0","summary":"2025年02月04日早盘10时22分，同源康医药-B股票出现异动，股价快速下跌5.06%。截至发稿，该股报22.500港元/股，成交量3000股，换手率0.00%，振幅2.53%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.57%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204102254abc19631&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204102254abc19631&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","BK1161","02410","BK1574","BK1515"],"gpt_icon":0},{"id":"2506934301","title":"同源康醫藥-B盤中異動 快速跳水7.20%報23.200港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2506934301","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506934301?lang=zh_tw&edition=fundamental","pubTime":"2025-01-27 13:28","pubTimestamp":1737955715,"startTime":"0","endTime":"0","summary":"2025年01月27日下午盘13时28分，同源康医药-B股票出现异动，股价急速跳水7.20%。截至发稿，该股报23.200港元/股，成交量6000股，换手率0.00%，振幅7.00%。资金方面，该股资金流入10.875万港元，流出1.1975万港元。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.50%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。TY-2136b为自主研发、口服ROS1/NTRK抑制剂,用于治疗实体瘤。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127132835a230edba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250127132835a230edba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","BK1515","09939","02410","BK1574"],"gpt_icon":0},{"id":"2505617868","title":"同源康醫藥受邀參加第43屆摩根大通醫療健康大會（JPM大會）","url":"https://stock-news.laohu8.com/highlight/detail?id=2505617868","media":"美通社","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505617868?lang=zh_tw&edition=fundamental","pubTime":"2025-01-24 16:27","pubTimestamp":1737707220,"startTime":"0","endTime":"0","summary":"上海和旧金山2025年1月24日 /美通社/ -- 浙江同源康医药股份有限公司荣幸受邀参加于美国旧金山举行的第43届摩根大通医疗健康大会。同源康医药核心产品艾多替尼片已获中国药监局同意开展关键性Ⅱ期临床试验用于申请附条件批准上市，预计将于今年在中国获得附条件上市。对于同源康医药而言，2025年将是一个重要的起点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4603731_ZH03731_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["BK4534","LU2430703178.SGD","LU0976567544.SGD","LU1244550494.USD","02410","LU0106831901.USD","LU0211327993.USD","LU0211331839.USD","LU0267386448.USD","LU2552382132.HKD","LU2237443382.USD","LU2237443895.HKD","BK4581","LU1084165304.USD","LU2237443622.USD","BK4533","LU0070302665.USD","LU1119994496.HKD","LU2505996681.GBP","LU1670627923.USD","LU1670628061.USD","LU0256863811.USD","LU1988902786.USD","LU2264538146.SGD","LU0417517546.SGD","LU1917777945.USD","LU0234572021.USD","LU1496350171.SGD","LU2430703251.USD","LU0320765646.SGD","LU0211326839.USD","IE00BYXW3230.USD","IE00B3S45H60.SGD","IE0034235295.USD","IE00BBT3K403.USD","LU2106854487.HKD","IE000M9KFDE8.USD","IE00BDRTCR15.USD","LU0211326755.USD","LU1267930490.SGD","LU2552382058.USD","BK4516","BK4550","IE00BKDWB100.SGD","IE00BDCRKT87.USD","LU0683600562.USD","LU0203345920.USD","IE00BJTD4N35.SGD","IE00B1XK9C88.USD","LU1720051017.SGD"],"gpt_icon":0},{"id":"2504827420","title":"恒指重回20000點上方，同源康醫藥-B漲超22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504827420","media":"中新经纬","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504827420?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 12:18","pubTimestamp":1737346734,"startTime":"0","endTime":"0","summary":"截至午盘，恒指涨2.33%，收复20000点；恒生国企指数涨2.30%，恒生科技指数涨3.17%。医药股走强，同源康医药-B涨超22%，药明康德劲升7%，药明生物涨逾5%。中金策略分析，开年以来港股市场连续两周回调，恒指一度逼近19000点，RSI也在周初降至32.1，接近超卖。中金策略此前提示，19000点是恒指日线、周线和月线的关键支撑位，不出意外的话可以得到支撑。中金策略认为，拉长时间看，市场仍没有摆脱震荡格局。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120122605986c4644&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120122605986c4644&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["09939","HSI","BK1161","02410","02833","BK1574","MCHmain","513600","HHImain","BK1515"],"gpt_icon":0},{"id":"2504844137","title":"港股異動 | 同源康醫藥-B(02410)盤中漲超34% 核心產品正進行臨牀試驗 機構指其具備較強競爭","url":"https://stock-news.laohu8.com/highlight/detail?id=2504844137","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504844137?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 11:34","pubTimestamp":1737344094,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，同源康医药-B盘中涨超34%，截至发稿，涨28.43%，报25.3港元，成交额105.44万港元。公司已建立由11款候选药物组成的管线，包括2个低风险产品TY-9591、TY-302，5款创新临床产品，4款处于临床前阶段的产品。国元国际此前指，公司在小细胞肺癌脑转移有较大的创新性，有较强的竞争优势。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1240155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","BK1515","BK1574","BK1161","BK1141","02410","03347","BK1576","09939","159938"],"gpt_icon":0},{"id":"2504444910","title":"同源康醫藥-B盤中異動 大幅拉昇6.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504444910","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504444910?lang=zh_tw&edition=fundamental","pubTime":"2025-01-20 09:32","pubTimestamp":1737336765,"startTime":"0","endTime":"0","summary":"2025年01月20日早盘09时32分，同源康医药-B股票出现异动，股价大幅拉升6.60%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.61%。其相关个股中，北海康成-B、同源康医药-B、华康生物医学涨幅较大，振幅较大的相关个股有北海康成-B、华康生物医学、欧康维视生物-B，振幅分别为6.08%、5.97%、5.76%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120093245a2282886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250120093245a2282886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1515","BK1574","BK1161","02410","09939"],"gpt_icon":0},{"id":"2504184881","title":"同源康醫藥－Ｂ(02410)股價上升9.756%，現價港幣$18.0","url":"https://stock-news.laohu8.com/highlight/detail?id=2504184881","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504184881?lang=zh_tw&edition=fundamental","pubTime":"2025-01-17 15:27","pubTimestamp":1737098820,"startTime":"0","endTime":"0","summary":"[上升股]同源康医药－Ｂ(02410) 股价在下午03:27比前收市价上升9.756%，现股价为港币$18.0。至目前为止，今日最高价为$18.0，而最低价为$16.46。总成交量为1.05万股，总成交金额为港币$18.195万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112133338093_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2501171055/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["09939","BK1161","02410","159938","BK1574","BK1515"],"gpt_icon":0},{"id":"2504131298","title":"同源康醫藥-B盤中異動 下午盤大幅拉昇6.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2504131298","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504131298?lang=zh_tw&edition=fundamental","pubTime":"2025-01-17 15:26","pubTimestamp":1737098803,"startTime":"0","endTime":"0","summary":"2025年01月17日下午盘15时26分，同源康医药-B股票出现异动，股价急速拉升6.71%。同源康医药-B股票所在的生物技术行业中，整体涨幅为0.72%。其相关个股中，华康生物医学、北海康成-B、歌礼制药-B涨幅较大，振幅较大的相关个股有北海康成-B、华康生物医学、帝王国际投资，振幅分别为53.91%、38.46%、16.28%。同源康医药-B公司简介：浙江同源康医药股份有限公司是一家致力于开发及商业化医药产品的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501171526439869844d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501171526439869844d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02410","BK1161","BK1515","BK1574","09939"],"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":4,"totalSize":132,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02410\",params:#limit:5,,,undefined,":[{"date":"2025-03-27","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743039000000,"name":null,"time":"","dateTimestamp":1743004800000,"actualEps":null},{"date":"2024-08-30","symbol":"02410","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724981400000,"name":null,"time":"","dateTimestamp":1724947200000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02410\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02410\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02410\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02410","date":"2025-04-28","current":-24.607343,"percent":0.464286,"low":-45.171338,"twenty":-28.737926,"median":-24.349989,"eighty":-19.285755,"high":-10.104382,"avg":-24.668027,"sd":6.685861,"marketCap":10123817831},"quantilePoints":[{"date":"2024-08-23","current":-18.036629,"twenty":-16.647141,"median":-14.72623,"eighty":-12.008468,"marketCap":8010053668},{"date":"2024-08-30","current":-17.916348,"twenty":-18.108709,"median":-17.490261,"eighty":-14.277882,"marketCap":8010053668},{"date":"2024-09-06","current":-22.38992,"twenty":-20.387629,"median":-17.957821,"eighty":-15.985061,"marketCap":10531737231},{"date":"2024-09-13","current":-25.215246,"twenty":-24.52304,"median":-18.767123,"eighty":-16.911292,"marketCap":11829662594},{"date":"2024-09-20","current":-22.432724,"twenty":-24.518581,"median":-20.496807,"eighty":-17.208183,"marketCap":10587362603},{"date":"2024-09-27","current":-24.719835,"twenty":-24.497927,"median":-22.38992,"eighty":-17.671485,"marketCap":11736953639},{"date":"2024-10-04","current":-24.95032,"twenty":-24.87878,"median":-23.321155,"eighty":-17.932937,"marketCap":11792579012},{"date":"2024-10-10","current":-25.38933,"twenty":-24.941363,"median":-23.362473,"eighty":-17.973583,"marketCap":11922371548},{"date":"2024-10-18","current":-26.355956,"twenty":-25.311733,"median":-23.798709,"eighty":-18.108709,"marketCap":12311749157},{"date":"2024-10-25","current":-24.571342,"twenty":-25.374683,"median":-24.122054,"eighty":-18.545067,"marketCap":11477368567},{"date":"2024-11-01","current":-18.445843,"twenty":-25.311733,"median":-23.998666,"eighty":-18.584118,"marketCap":8621932768},{"date":"2024-11-08","current":-20.323115,"twenty":-25.278482,"median":-23.623818,"eighty":-17.973583,"marketCap":9456313359},{"date":"2024-11-15","current":-19.45318,"twenty":-25.171449,"median":-23.425489,"eighty":-18.108709,"marketCap":8955685004},{"date":"2024-11-22","current":-24.620137,"twenty":-24.988066,"median":-23.362473,"eighty":-18.406793,"marketCap":11329034239},{"date":"2024-11-29","current":-31.047836,"twenty":-25.311733,"median":-23.554037,"eighty":-18.584118,"marketCap":14277178993},{"date":"2024-12-06","current":-34.758675,"twenty":-25.786797,"median":-23.737743,"eighty":-19.168188,"marketCap":15945940174},{"date":"2024-12-13","current":-35.961329,"twenty":-26.0415,"median":-24.070769,"eighty":-19.324298,"marketCap":16465110319},{"date":"2024-12-20","current":-44.500897,"twenty":-30.298107,"median":-24.44033,"eighty":-19.494791,"marketCap":20284719244},{"date":"2024-12-27","current":-43.273475,"twenty":-31.455257,"median":-24.553474,"eighty":-19.619623,"marketCap":19709923726},{"date":"2025-01-03","current":-39.042242,"twenty":-33.760908,"median":-24.669986,"eighty":-19.709581,"marketCap":17800119264},{"date":"2025-01-10","current":-16.73771,"twenty":-34.083555,"median":-24.719835,"eighty":-19.709581,"marketCap":7602134269},{"date":"2025-01-17","current":-16.071561,"twenty":-33.760908,"median":-24.553474,"eighty":-18.860667,"marketCap":7305465614},{"date":"2025-01-24","current":-20.268382,"twenty":-32.413923,"median":-24.349989,"eighty":-19.230133,"marketCap":9270895450},{"date":"2025-01-28","current":-18.549699,"twenty":-31.591026,"median":-24.122054,"eighty":-18.549699,"marketCap":8529223814},{"date":"2025-02-07","current":-17.965815,"twenty":-31.472067,"median":-23.871541,"eighty":-18.275892,"marketCap":8214013368},{"date":"2025-02-14","current":-19.878813,"twenty":-31.451054,"median":-23.623818,"eighty":-18.275892,"marketCap":9066935750},{"date":"2025-02-21","current":-25.066745,"twenty":-31.047836,"median":-23.789321,"eighty":-18.32609,"marketCap":11495910358},{"date":"2025-02-28","current":-26.244856,"twenty":-30.411824,"median":-23.765234,"eighty":-18.39703,"marketCap":11996538712},{"date":"2025-03-07","current":-24.725844,"twenty":-30.135297,"median":-23.927628,"eighty":-18.445843,"marketCap":11347576030},{"date":"2025-03-14","current":-23.101371,"twenty":-29.84324,"median":-23.977848,"eighty":-18.549699,"marketCap":10605904394},{"date":"2025-03-21","current":-22.868028,"twenty":-28.789228,"median":-23.789321,"eighty":-18.691799,"marketCap":10494653649},{"date":"2025-03-28","current":-28.703724,"twenty":-28.703724,"median":-23.977848,"eighty":-19.110968,"marketCap":13146129748},{"date":"2025-04-03","current":-29.204856,"twenty":-29.744706,"median":-24.122054,"eighty":-19.131966,"marketCap":12070705875},{"date":"2025-04-11","current":-24.387234,"twenty":-29.307899,"median":-24.067881,"eighty":-19.145106,"marketCap":10012567086},{"date":"2025-04-17","current":-24.599189,"twenty":-28.955479,"median":-24.067881,"eighty":-19.224594,"marketCap":10123817831},{"date":"2025-04-25","current":-24.758022,"twenty":-28.755026,"median":-24.236021,"eighty":-19.282593,"marketCap":10197984995},{"date":"2025-04-28","current":-24.607343,"twenty":-28.737926,"median":-24.349989,"eighty":-19.285755,"marketCap":10123817831}],"updateTime":1745927672214}}}